2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Gastrointestinal
1
Classical hematology
1
Conditions
Colorectal Neoplasms
28
Neoplasms
13
Colonic Neoplasms
12
Breast Neoplasms
12
Prostatic Neoplasms
9
Polycythemia Vera
9
Venous Thromboembolism
8
Multiple Myeloma
8
Recurrence
6
Carcinoma, Non-Small-Cell Lung
6
Rectal Neoplasms
5
Thrombocythemia, Essential
4
Ovarian Neoplasms
4
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Esophageal Neoplasms
4
Cardiovascular Diseases
4
Barrett Esophagus
4
Stomach Neoplasms
3
Precancerous Conditions
3
Melanoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Adenomatous Polyps
3
Adenoma
3
Tobacco Use Disorder
2
Thrombosis
2
Thromboembolism
2
Smoking Cessation
2
Interventions
Tranexamic Acid
13
Sodium Chloride
4
Misoprostol
4
Saline Solution
3
Enoxaparin
3
carbetocin
2
Tourniquets
2
Ringer's Lactate
2
Oxytocin
2
Endoscopic Mucosal Resection
2
Dalteparin
2
Aspirin
2
maleimide-polyethylene glycol-modified hemoglobin, MP4
1
bemiparin
1
Vitamin B 6
1
Vasopressins
1
Uterine Myomectomy
1
Uterine Artery Embolization
1
Ultrasonography
1
Tinzaparin
1
Thoracic Surgery, Video-Assisted
1
Terlipressin
1
Sutures
1
Surveys and Questionnaires
1
Surgicel
1
Standard of Care
1
Solutions
1
Sensitivity Training Groups
1
Rivaroxaban
1
Ringer's Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hemorrhage
×
Aspirin
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled
NCT03904732
2021-02-01
PEACOCS
Bayer
Completed
2,000,000 enrolled